Riskpilot← Back to searchSign inGet full accessLENS IMPLANT ApS
APSActiveCVR 89798310Lundbyesgade 32Medical specialists activities · NACE 8622Est. 19811 employees
Revenue 2025
DKK -65K
-129% vs 2024
EBITDA margin
664.6%
-184% vs 2024
Equity ratio
96.8%
Financial strength
Net profit 2025
DKK -1,7M
-5133% vs 2024
| Revenue | DKK -65K | -129% |
| EBITDA | DKK -432K | -184% |
| Net profit | DKK -1,7M | -5133% |
| Total assets | DKK 4,4M | -40% |
| Equity | DKK 4,3M | -39% |
| Employees | 1 | — |
Legal name
LENS IMPLANT ApS
CVR number
89798310
Legal form
Anpartsselskab
NACE code
8622 · Medical specialists activities
Founded
21. december 1981
Share capital
DKK 200.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede direktion
Company purpose
Selskabets formål er optagning af grus og sand fra havbunden, rederivirksomhed, fabrikation, handel og finansiering samt anden efter bestyrelsens skøn hermed forenelig virksomhed
Address
Lundbyesgade 32
Phone
+4574486928
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2.398 | 3.003 | -102 | 221 | -65 |
| Staff expenses | -386 | -388 | -378 | -374 | -367 |
| EBITDA | 2.011 | 2.615 | -480 | -152 | -432 |
| Depreciation & amort. | -3 | -3 | -0 | -0 | -0 |
| EBIT | 2.008 | 2.612 | -481 | -152 | -432 |
| Net financials | 11.942 | -10.100 | -3.480 | 186 | -1.261 |
| Profit before tax | 13.950 | -7.488 | -3.961 | 34 | -1.693 |
| Tax | 3.068 | 19 | -0 | -0 | -0 |
| Net profit | 10.882 | -7.507 | -3.961 | 34 | -1.693 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 27.595 | 19.750 | 11.362 | 7.391 | 4.440 |
| Equity | 21.423 | 12.916 | 7.955 | 6.989 | 4.296 |
| Long-term debt | 3.062 | 0 | 0 | 0 | 0 |
| Short-term debt | 3.110 | 6.834 | 3.407 | 402 | 143 |
| Total debt | 6.172 | 6.834 | 3.407 | 402 | 143 |
EBITDA margin
-43154100.0%
This company
15.8%
Market median
-273127315% vs market
20212025
Equity ratio
96.8%
This company
38.2%
Market median
+153% vs market
20212025
Return on equity
-39.4%
This company
18.4%
Market median
-314% vs market
20212025
Net profit margin
-169293800.0%
This company
8.1%
Market median
-2090047014% vs market
20212025
Asset turnover
-0.01×
This company
1.12×
Market median
-101% vs market
20212025
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via CVR / Virk · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via CVR / Virk · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via CVR / Virk · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via CVR / Virk · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
VJ Management | Management | 1981 – 2014 |
NK | Audit | 1981 – 2008 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Board of Directors | 1981 – 1994 | |
EL | Board of Directors | 1981 – 2012 |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 90–99.99% | 90–99.99% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LENS IMPLANT ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Viggo Jørgensen | Management | 0 companies |
| Niels Kristian Ladefoged | Audit | 0 companies |
| Jørn Slot Jørgensen | Board of Directors | 0 companies |
| Elke Lei | Board of Directors | 0 companies |